UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Interim analysis of a phase I/IIA trial assessing E39 + GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients

Gynecologic oncology, 2017-06, Vol.145, p.23-23

2017

Volltextzugriff (PDF)

A cost-effectiveness analysis of the AURELIA trial: Bevacizumab and paclitaxel offer a promising clinical and economic combination for platinum-resistant ovarian cancer

Gynecologic oncology, 2016-06, Vol.141, p.36-37

2016

Volltextzugriff (PDF)

Racial and ethnic outcome differences in the top five women’s cancers: A harmonized Surveillance, Epidemiology, and End Results study for diagnoses from 2000-2014

Gynecologic oncology, 2017-06, Vol.145, p.93-94

2017

Volltextzugriff (PDF)

Racial differences in molecular subtypes between black and white patients with endometrial cancer

Gynecologic oncology, 2017-06, Vol.145, p.11-12

2017

Volltextzugriff (PDF)

CTNNB1 predicts better progression-free survival in endometrioid endometrial cancer patients treated with chemotherapy

Gynecologic oncology, 2017-06, Vol.145, p.81-81

2017

Volltextzugriff (PDF)

Mutations and transcript expression of maternal embryonic leucine zipper kinase in endometrial cancer patients

Gynecologic oncology, 2017-06, Vol.145, p.87-88

2017

Volltextzugriff (PDF)

Proteogenomic alterations in black endometrioid endometrial cancer patients correlate with poor disease outcome

Gynecologic oncology, 2017-06, Vol.145, p.106-106

2017

Volltextzugriff (PDF)

MS7 a transcript-based diagnostic classifier for metastatic disease and worse progression-free survival in endometrioid endometrial cancer patients

Gynecologic oncology, 2017-06, Vol.145, p.12-12

2017

Volltextzugriff (PDF)

Nestin: A biomarker of aggressive uterine cancers

Gynecologic oncology, 2016-06, Vol.141, p.78-79

2016

Volltextzugriff (PDF)

Clinical assessments of MELK immunohistochemical expression in uterine cancer patients: A Gynecologic Cancer Center of Excellence study

Gynecologic oncology, 2016-06, Vol.141, p.153-153

2016

Volltextzugriff (PDF)

Surrogates of progression-free survival in endometrial cancer patients: An evaluation of necrosis and other measures of tissue composition

Gynecologic oncology, 2017-06, Vol.145, p.124-125

2017

Volltextzugriff (PDF)

Progestins and vitamin D inhibit CYP24A1 in vivo in ovarian cancer cell xenografts

Gynecologic oncology, 2015-04, Vol.137, p.204-204

2015

Volltextzugriff (PDF)

FIGO staging criteria is a meaningful clinical threshold for evaluating molecular signatures in serous ovarian cancer patients

Gynecologic oncology, 2015-04, Vol.137, p.188-188

2015

Volltextzugriff (PDF)

Progestins inhibit calcitriol-induced CYP24A1 in endometrial and ovarian cancer cells

Gynecologic oncology, 2015-04, Vol.137, p.64-65

2015

Volltextzugriff (PDF)

Proteomics of endometrial carcinogenesis: Identification of candidates underlying disease pathogenesis

Gynecologic oncology, 2014-06, Vol.133, p.137-137

2014

Volltextzugriff (PDF)

Phase I trial results of a folate receptor alpha-directed cancer vaccine (E39) in ovarian and endometrial cancer patients to prevent recurrence

Gynecologic oncology, 2014-06, Vol.133, p.40-41

2014

Volltextzugriff (PDF)

Identification of candidate circulating cisplatin resistance biomarkers from epithelial ovarian carcinoma cell secretomes

Gynecologic oncology, 2014-06, Vol.133, p.17-18

2014

Volltextzugriff (PDF)

Diminished survival of separated, divorced, or widowed uterine cancer patients: A potential focus for survivorship programs

Gynecologic oncology, 2014-06, Vol.133, p.206-206

2014

Volltextzugriff (PDF)

Curated Ovarian Database-derived identification of genes predicting survival in primary serous epithelial ovarian cancer

Gynecologic oncology, 2014-06, Vol.133, p.120-120

2014

Volltextzugriff (PDF)

Correlation of survival-stratified proteomic and curated gene data reveal a three-protein biomarker panel that predicts long-term survival of patients with primary epithelial ovarian cancer

Gynecologic oncology, 2014-06, Vol.133, p.205-206

2014

Volltextzugriff (PDF)

Pharmacologic inhibition of polo-like kinase 1 enhances paclitaxel-based cell killing in taxol-resistant ovarian cancer cells

Gynecologic oncology, 2014-06, Vol.133, p.124-124

2014

Volltextzugriff (PDF)

Ovarian cancers with nuclear special AT-rich sequence-binding protein 1 and cytoplasmic AT-rich interactive domain-containing protein 1A are rare, drug-resistant, and deadly

Gynecologic oncology, 2014-06, Vol.133, p.114-115

2014

Volltextzugriff (PDF)

Pathogenesis of ARID1A -driven gynecologic cancer

Gynecologic oncology, 2014-06, Vol.133, p.19-20

2014

Volltextzugriff (PDF)

Trends in uterine cancer incidence in the United States and Asian countries: A population analysis of 576,558 of women

Gynecologic oncology, 2018-06, Vol.149, p.160-161

2018

Volltextzugriff (PDF)

Age matters when predicting overall survival benefit of combined chemotherapy and radiation versus radiation alone in high risk endometrial cancer: A study of 20,000 women using PORTEC-3 criteria

Gynecologic oncology, 2020-10, Vol.159, p.11-11

2020

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(56)
Reviews
(1)

Sprache

Englisch
(57)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(23)
Obstetrics And Gynecology
(23)
Science & Technology
(7)
Life Sciences & Biomedicine
(5)
Humans
(3)
Physical Sciences
(3)
Proteins
(3)
400600 - Radiation Chemistry
(2)
Amino Acids
(2)
Anions
(2)
Aqueous Solutions
(2)
Biochemistry & Molecular Biology
(2)
Biological And Medical Sciences
(2)
Carboxylic Acids
(2)
Cell Biology
(2)
Charged Particles
(2)
Chemical Radiation Effects
(2)
Chemical Reactions
(2)
Chemistry
(2)
Chemistry, Physical
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gynecologic Oncology
(46)
Bulletin Of Spanish Studies
(2)
J. Phys. Chem.;
(2)
Journal Of Physical Chemistry
(2)
Neurophotonics
(2)
Breast Cancer Research And Treatment
(1)
Cb/current Biology
(1)
Current Biology
(1)
Gene Therapy
(1)
Oncogene
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interim analysis of a phase I/IIA trial assessing E39 + GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients

A cost-effectiveness analysis of the AURELIA trial: Bevacizumab and paclitaxel offer a promising clinical and economic combination for platinum-resistant ovarian cancer

Racial and ethnic outcome differences in the top five women’s cancers: A harmonized Surveillance, Epidemiology, and End Results study for diagnoses from 2000-2014

Racial differences in molecular subtypes between black and white patients with endometrial cancer

CTNNB1 predicts better progression-free survival in endometrioid endometrial cancer patients treated with chemotherapy

Mutations and transcript expression of maternal embryonic leucine zipper kinase in endometrial cancer patients

Proteogenomic alterations in black endometrioid endometrial cancer patients correlate with poor disease outcome

MS7 a transcript-based diagnostic classifier for metastatic disease and worse progression-free survival in endometrioid endometrial cancer patients

Nestin: A biomarker of aggressive uterine cancers

Clinical assessments of MELK immunohistochemical expression in uterine cancer patients: A Gynecologic Cancer Center of Excellence study

Surrogates of progression-free survival in endometrial cancer patients: An evaluation of necrosis and other measures of tissue composition

Progestins and vitamin D inhibit CYP24A1 in vivo in ovarian cancer cell xenografts

FIGO staging criteria is a meaningful clinical threshold for evaluating molecular signatures in serous ovarian cancer patients

Progestins inhibit calcitriol-induced CYP24A1 in endometrial and ovarian cancer cells

Proteomics of endometrial carcinogenesis: Identification of candidates underlying disease pathogenesis

Phase I trial results of a folate receptor alpha-directed cancer vaccine (E39) in ovarian and endometrial cancer patients to prevent recurrence

Identification of candidate circulating cisplatin resistance biomarkers from epithelial ovarian carcinoma cell secretomes

Diminished survival of separated, divorced, or widowed uterine cancer patients: A potential focus for survivorship programs

Curated Ovarian Database-derived identification of genes predicting survival in primary serous epithelial ovarian cancer

Correlation of survival-stratified proteomic and curated gene data reveal a three-protein biomarker panel that predicts long-term survival of patients with primary epithelial ovarian cancer

Pharmacologic inhibition of polo-like kinase 1 enhances paclitaxel-based cell killing in taxol-resistant ovarian cancer cells

Ovarian cancers with nuclear special AT-rich sequence-binding protein 1 and cytoplasmic AT-rich interactive domain-containing protein 1A are rare, drug-resistant, and deadly

Pathogenesis of ARID1A -driven gynecologic cancer

Trends in uterine cancer incidence in the United States and Asian countries: A population analysis of 576,558 of women

Age matters when predicting overall survival benefit of combined chemotherapy and radiation versus radiation alone in high risk endometrial cancer: A study of 20,000 women using PORTEC-3 criteria

Suchergebnisse filtern